BridgeBio Pharma Inc logo

BridgeBio Pharma Inc

NAS:BBIO (USA)  
$ 26.83 -1.53 (-5.39%) 10:08 PM EST
At Loss
Volume:
1.88M
Avg Vol (2M):
1.73M
Also Trade In:
Volume:
1.88M
At Loss
Avg Vol (2M):
1.73M

Business Description

Description
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.
Name Current Vs Industry Vs History
Cash-To-Debt 0.25
Equity-to-Asset -2.48
Debt-to-Equity -1.29
Debt-to-EBITDA -3.08
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.6
Distress
Grey
Safe
Beneish M-Score -5.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.32
9-Day RSI 34.2
14-Day RSI 36.71
6-1 Month Momentum % 16.19
12-1 Month Momentum % 89.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.32
Quick Ratio 3.32
Cash Ratio 3.02
Days Payable 1033.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.5
Shareholder Yield % -8.74

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 73.71
Operating Margin % -6443.56
Net Margin % -6913.92
FCF Margin % -5686.62
ROA % -108.88
ROIC % -519.36
ROC (Joel Greenblatt) % -2513.15
ROCE % -120.38

Financials (Next Earnings Date:2024-05-03 Est.)

BBIO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BBIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BridgeBio Pharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 9.303
EPS (TTM) ($) -3.94
Beta 1.11
Volatility % 119
14-Day RSI 36.71
14-Day ATR ($) 1.464859
20-Day SMA ($) 28.77
12-1 Month Momentum % 89.06
52-Week Range ($) 12.75 - 44.32
Shares Outstanding (Mil) 184.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BridgeBio Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

BridgeBio Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

BridgeBio Pharma Inc Frequently Asked Questions

What is BridgeBio Pharma Inc(BBIO)'s stock price today?
The current price of BBIO is $26.83. The 52 week high of BBIO is $44.32 and 52 week low is $12.75.
When is next earnings date of BridgeBio Pharma Inc(BBIO)?
The next earnings date of BridgeBio Pharma Inc(BBIO) is 2024-05-03 Est..
Does BridgeBio Pharma Inc(BBIO) pay dividends? If so, how much?
BridgeBio Pharma Inc(BBIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1